On the role of NOS1 ex1f‐VNTR in ADHD—allelic, subgroup, and meta‐analysis

Attention deficit/ hyperactivity disorder (ADHD) is a heritable neurodevelopmental disorder featuring complex genetics with common and rare variants contributing to disease risk. In a high proportion of cases, ADHD does not remit during adolescence but persists into adulthood. Several studies suggest that NOS1, encoding nitric oxide synthase I, producing the gaseous neurotransmitter NO, is a candidate gene for (adult) ADHD. We here extended our analysis by increasing the original sample, adding two further samples from Norway and Spain, and conducted subgroup and co‐morbidity analysis. Our previous finding held true in the extended sample, and also meta‐analysis demonstrated an association of NOS1 ex1f‐VNTR short alleles with adult ADHD (aADHD). Association was restricted to females, as was the case in the discovery sample. Subgroup analysis on the single allele level suggested that the 21‐repeat allele caused the association. Regarding subgroups, we found that NOS1 was associated with the hyperactive/impulsive ADHD subtype, but not to pure inattention. In terms of comorbidity, major depression, anxiety disorders, cluster C personality disorders and migraine were associated with short repeats, in particular the 21‐repeat allele. Also, short allele carriers had significantly lower IQ. Finally, we again demonstrated an influence of the repeat on gene expression in human post‐mortem brain samples. These data validate the role of NOS‐I in hyperactive/impulsive phenotypes and call for further studies into the neurobiological underpinnings of this association. © 2015 Wiley Periodicals, Inc.

[1]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  Kourosh Masoumeh Arami,et al.  Neuronal Nitric Oxide Synthase , 2017 .

[3]  K. Lesch,et al.  Sex- and Subtype-Related Differences of Personality Disorders (Axis II) and Personality Traits in Persistent ADHD , 2016, Journal of attention disorders.

[4]  A. Alttoa,et al.  Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders , 2015, Genes, brain, and behavior.

[5]  M. Quirynen,et al.  Oral health: Risk definition in halitosis , 2014, BDJ.

[6]  A. Bao,et al.  Nitric oxide synthase and nitric oxide alterations in chronically stressed rats: A model for nitric oxide in major depressive disorder , 2014, Psychoneuroendocrinology.

[7]  Astrid Dempfle,et al.  Internalizing and externalizing behavior in adult ADHD , 2014, ADHD Attention Deficit and Hyperactivity Disorders.

[8]  D. Swaab,et al.  Decreased NOS1 expression in the anterior cingulate cortex in depression. , 2013, Cerebral cortex.

[9]  F. Guimarães,et al.  Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: Involvement of nitric oxide , 2013, European Neuropsychopharmacology.

[10]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[11]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[12]  P. Lichtenstein,et al.  Developmental twin study of attention problems: high heritabilities throughout development. , 2013, JAMA psychiatry.

[13]  Tim Hahn,et al.  NOS1 ex1f‐VNTR polymorphism affects prefrontal oxygenation during response inhibition tasks , 2012, Human brain mapping.

[14]  K. Lesch,et al.  Association of a functional variant of the nitric oxide synthase 1 gene with personality, anxiety, and depressiveness , 2012, Development and Psychopathology.

[15]  Y. Yazır,et al.  Inhibition of Neuronal Nitric Oxide Synthase and Soluble Guanylate Cyclase Prevents Depression‐Like Behaviour in Rats Exposed to Chronic Unpredictable Mild Stress , 2012, Basic & clinical pharmacology & toxicology.

[16]  P. Lichtenstein,et al.  Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins , 2012, Psychological Medicine.

[17]  J. Tanus-Santos,et al.  Inducible nitric oxide synthase haplotype associated with migraine and aura , 2012, Molecular and Cellular Biochemistry.

[18]  B. Franke,et al.  The genetics of attention deficit/hyperactivity disorder in adults, a review , 2011, Molecular Psychiatry.

[19]  L. Kiemeney,et al.  DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders , 2011, Neuropsychopharmacology.

[20]  F. López-Muñoz,et al.  Corticotropin-Releasing Factor and Hypothalamic–Pituitary–Adrenal Axis Regulation of Behavioral Stress Response and Depression , 2011 .

[21]  Thomas Dresler,et al.  NOS1 ex1f-VNTR polymorphism influences prefrontal brain oxygenation during a working memory task , 2011, NeuroImage.

[22]  K. Oedegaard,et al.  Adult attention deficit hyperactivity disorder is associated with migraine headaches , 2011, European Archives of Psychiatry and Clinical Neuroscience.

[23]  M. Maes,et al.  Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. , 2011, Journal of affective disorders.

[24]  Marika Paaver,et al.  A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity , 2011, Psychopharmacology.

[25]  A. Lundervold,et al.  Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder , 2010, Expert review of neurotherapeutics.

[26]  K. Lesch,et al.  The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity , 2010, Psychopharmacology.

[27]  Stefan Johansson,et al.  Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD , 2010, Neuropsychopharmacology.

[28]  J. Haavik,et al.  Bipolar symptoms in adult attention-deficit/hyperactivity disorder: a cross-sectional study of 510 clinically diagnosed patients and 417 population-based controls. , 2010, The Journal of clinical psychiatry.

[29]  Michael Gill,et al.  Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. , 2009, Archives of general psychiatry.

[30]  J. Kurth,et al.  The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease , 2009, Journal of neuroscience research.

[31]  Benjamin M. Neale,et al.  Genome-wide association studies in ADHD , 2009, Human Genetics.

[32]  C. Gillberg,et al.  Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5‐microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[33]  S. A. Stevenson,et al.  Altered gene expression in mice selected for high maternal aggression , 2007, Genes, brain, and behavior.

[34]  K. Lesch,et al.  Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center , 2007, European Archives of Psychiatry and Clinical Neuroscience.

[35]  R. Nelson,et al.  Pleiotropic contributions of nitric oxide to aggressive behavior , 2006, Neuroscience & Biobehavioral Reviews.

[36]  S. Faraone,et al.  Candidate gene studies of attention-deficit/hyperactivity disorder. , 2006, The Journal of clinical psychiatry.

[37]  D Saur,et al.  A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function , 2006, Molecular Psychiatry.

[38]  Joseph Biederman,et al.  The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies , 2005, Psychological Medicine.

[39]  A. Moorman,et al.  Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data , 2003, Neuroscience Letters.

[40]  R. Spanagel,et al.  The Neuronal Nitric Oxide Synthase Gene Is Critically Involved in Neurobehavioral Effects of Alcohol , 2002, The Journal of Neuroscience.

[41]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[42]  R. Nelson,et al.  Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Gammie,et al.  Maternal Aggression Is Reduced in Neuronal Nitric Oxide Synthase-Deficient Mice , 1999, The Journal of Neuroscience.

[44]  S. Snyder,et al.  Nitric oxide and carbon monoxide: parallel roles as neural messengers 1 Published on the World Wide Web on 21 October 1997. 1 , 1998, Brain Research Reviews.

[45]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[46]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[47]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[48]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[49]  S. Joca,et al.  Nitric Oxide Signaling in Depression and Antidepressant Action , 2016 .

[50]  L. Kiemeney,et al.  DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders , 2012, Neuropsychopharmacology.

[51]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[52]  D. Rujescu,et al.  Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. , 2009, Archives of general psychiatry.

[53]  D. Rujescu,et al.  Influence of NOS 1 on Verbal Intelligence and Working Memory in Both Patients With Schizophrenia and Healthy Control Subjects , 2009 .

[54]  K. Lesch,et al.  Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals. , 2007, Journal of neural transmission. Supplementum.